Zhejiang Shengda Pharm (603079) — Cash Flow-to-Debt Ratio
Zhejiang Shengda Pharm (603079) has a Cash Flow-to-Debt Ratio of 0.08x as of September 2025, meaning its operating cash flow of CN¥45.27 Million could theoretically repay 0% of its total liabilities (CN¥542.15 Million) in one year. See 603079 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Zhejiang Shengda Pharm Cash Flow-to-Debt Ratio (2012–2025)
Historical debt coverage capacity for Zhejiang Shengda Pharm across 14 annual periods. Also explore net asset growth rate of Zhejiang Shengda Pharm to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Zhejiang Shengda Pharm (2012–2025)
Year-by-year debt coverage analysis for Zhejiang Shengda Pharm. For market capitalisation and broader financial context, see Zhejiang Shengda Pharm (603079) total market value.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.24x | CN¥138.88 Million | CN¥583.75 Million | ▼ -19.3% |
| 2024 | 0.29x | CN¥147.88 Million | CN¥501.34 Million | ▲ +105.7% |
| 2023 | 0.14x | CN¥64.42 Million | CN¥449.20 Million | ▲ +9.8% |
| 2022 | 0.13x | CN¥40.72 Million | CN¥311.76 Million | ▼ -25.0% |
| 2021 | 0.17x | CN¥74.46 Million | CN¥427.84 Million | ▼ -80.4% |
| 2020 | 0.89x | CN¥333.20 Million | CN¥375.80 Million | ▲ +840.2% |
| 2019 | 0.09x | CN¥58.55 Million | CN¥620.88 Million | ▼ -54.9% |
| 2018 | 0.21x | CN¥88.69 Million | CN¥424.29 Million | ▼ -52.4% |
| 2017 | 0.44x | CN¥95.33 Million | CN¥217.27 Million | ▲ +81.1% |
| 2016 | 0.24x | CN¥73.00 Million | CN¥301.35 Million | ▼ -69.7% |
| 2015 | 0.80x | CN¥148.07 Million | CN¥185.05 Million | ▲ +419.6% |
| 2014 | 0.15x | CN¥34.40 Million | CN¥223.40 Million | ▼ -67.2% |
| 2013 | 0.47x | CN¥105.28 Million | CN¥224.00 Million | ▲ +37.2% |
| 2012 | 0.34x | CN¥110.08 Million | CN¥321.43 Million | — |